Summary A proteinase accumulated in breast secretions from women with breast cancer has been characterised. Inhibition of the proteolytic activity of breast secretions by pepstatin A showed that the main enzyme involved was an aspartyl proteinase. Determination of its cleavage specificity by SDS-PAGE and (Miller et al., 1981; Hill et al., 1983; Rose, 1986) , mutagenic agents (Petrakis et al., 1980; Scott & Miller, 1990) and toxic substances (Petrakis et al., 1978 
Over recent years, cytological and biochemical analyses of secretions obtained from the nipple of nonlactating women have been useful to assess the metabolic activity within the mammary gland as well as to better understand the natural history of breast cancer. Thus, cytological studies performed by different groups (Sartorius et al., 1977; King et al., 1983; Petrakis et al., 1987; Wrensch et al., 1992) have revealed the presence of abnormal epithelial cells in breast fluids from women with breast diseases, allowing the identification of women who are at greater risk of developing breast cancer. Similarly, biochemical analyses have demonstrated that these fluids accumulate different substances which might be involved in the tumour process. These products include hormones (Miller et al., 1981; Hill et al., 1983; Rose, 1986) , mutagenic agents (Petrakis et al., 1980; Scott & Miller, 1990) and toxic substances (Petrakis et al., 1978) . In (Sa'nchez et al., 1992b) .
In the course of these studies on breast fluid composition, it became apparent that some secretions and mainly those obtained from patients with breast cancer contained proteolytic activities of unknown nature. Since proteinases have been proposed to play an important role in the developing of tumour processes (Gottessman, 1990) , studies were undertaken to define the nature and properties of the putative proteolytic enzymes present in breast secretions from women with breast cancer. In this work we present evidence that these fluids accumulate cathepsin D, an aspartyl proteinase of potential importance in the malignant transformation of mammary tissue and in breast cancer spread (Vignon et al., 1986; Briozzo et al., 1988 Other biochemical assays Protein concentration in breast secretions and tumour cytosols was determined by the Bradford method (Bradford, 1976 ) using bovine gamma globulin as standard. Oestrogen receptors were measured by enzyme-immunoassay using a commercially available kit from Abbott Laboratories (North Chicago, IL). Breast tumours were considered Oestrogen receptor positive (ER +) if they contained more than 10 fmol mg-' of cytosolic protein.
Amino acid sequence analysis Direct sequencing of protein fragments separated by SDS-PAGE was accomplished according to the method of Matsudaira (1987) . Proteins were electrophoretically transferred to a polyvinylidine fluoride membrane (PVDF) at 70 mA for 1 h in a Bio-Rad Trans Blot apparatus with a buffer containing 10 mM 3-(cyclohexylamino)-1-propanesulfonic acid, 4 mM NaOH, and 10% (v/v) (Figure 2 ). Since this inhibitor is very specific against aspartic proteinases, these results indicated that the enzyme responsible for the major proteolytic activity present in breast secretions was an aspartyl-proteinase. It should be also noted that EDTA displayed a partial inhibitory activity, suggesting that additional enzymes such as metalloproteinases could be present in these breast fluids.
Taking into account the previous reports have indicated that the aspartyl-proteinase cathepsin D is the predominant proteinase secreted by breast cancer cells (Briozzo et al., 1988) , we examined the possibility that the major enzymatic activity detected in breast secretions was due to this proteinase. To do that, and since the minute amounts of breast fluids which are usually available precluded the isolation of the putative cathepsin D, we performed functional assays with breast secretions by comparison of the cleavage specificity of the aspartyl proteinase present in the fluids with the corresponding one to purified cathepsin D. Thus, we carried out limited proteolysis on albumin and determined the NH2-terminal sequence of the predominant fragments separated by SDS-PAGE. The results obtained are shown in Figure 3 . As can be seen, the pattern of fragments obtained upon digestion with a breast secretion from a women with breast cancer was identical to the one obtained with cathepsin D. In addition, amino acid sequencing allowed to confirm the identity between the corresponding fragments obtained from both sources (Figure 3 ). The pattern of fragments obtained by using other proteolytic enzymes including pepsin and cathepsin B was clearly distinct (data not shown).
Quantification of cathepsin D in breast secretions
The above functional studies suggested that the aspartylproteinase activity detected in breast secretions was due, at least in part, to cathepsin D. To provide further insight on this question, as well as to evaluate the possible clinical significance of the presence of cathepsin D in breast secretions, we undertook the quantification of this proteinase in nipple aspirates obtained from control women without breast pathologies and from patients with benign and malignant breast diseases. Cathepsin D was measured by an immunoradiometric assay in secretions from women belonging to the different groups and the results obtained are shown in Figure 4 . The average concentration of this proteinase in secretions from controls and from patients with benign disease was very similar (2.9 ± 0.6 fmol jig-' of total protein and 2.1 ± 0.3 fmol,tg-', respectively). By contrast, the levels obtained in secretions from tumour-bearing breasts were significantly higher (7.2 ± 2.2 fmol ig-'). In addition, this value was also higher than the one obtained by measurement of cathepsin D in fluids from contralateral breast of women with cancer (3.6 ± 0.8 fmol ig-1). The 
Discussion
In this work we have presented structural and functional evidences indicating that the major proteolytic activity detected in breast secretions corresponds to cathepsin D. In addition, we show that accumulation of this proteinase in mammary fluids is significantly associated with breast carcinoma.
The first purpose of this study was the identification of proteolytic enzymes present in breast secretions. The finding that an aspartyl-proteinase could account for a significant part of the breast fluids proteolytic activity prompted us to consider its possible relationship to cathepsin D, a lysosomal aspartyl proteinase proposed to be involved in breast cancer (Rochefort, 1990) . The relationship between breast fluid proteinase and cathepsin D was initially based on functional findings since both enzymes displayed the same specificity as judged by amino acid sequencing of the fragments produced by their degrading activity on albumin. In addition, After these results indicating that cathepsin D is a major proteinase in breast secretions, we tried to determine the occurrence of possible differences in the levels of cathepsin D in mammary fluids obtained from control women and from patients with benign and malignant breast diseases. The results obtained indicated that fluids from patients with breast cancer showed significantly higher levels of cathepsin D than those from control women and from patients with benign breast diseases. In addition, cathepsin D levels in fluids from contralateral breast of patients with breast cancer were also lower than those from tumour-bearing breasts.
According to these data, it can be suggested that breast epithelium and specially the one from patients with breast cancer, has the ability to synthesise and secrete cathepsin D. After 45 min at 37°C, samples were analysed by SDS-PAGE, blotted to PVDF membranes and subjected to amino acid sequence analysis. The sequences obtained in the major bands are indicated by using the one-letter amino acid code (Maniatis et al., 1982) . This finding agrees well with in vitro results from Briozzo et al. (1988) , indicating that this enzyme is the predominant proteinase secreted by breast cancer cells in culture medium. In these breast cancer cells, cathepsin D is an oestrogen induced protein, therefore it is possible that the finding of elevated concentrations of this proteinase in breast secretions can be a consequence of oestrogen stimulation of mammary epithelium. However, since the mechanisms controlling cathepsin D expression have not been yet elucidated, a possible role of additional stimuli or the existence of cooperative interactions between different hormones or growth factors should not be excluded.
Since cathepsin D values in breast tumour cytosol have been proposed as a marker for predicting relapse-free survival in breast cancer patients (Spyratos et al., 1989; Thorpe et al., 1989; Tandon et al., 1990; Duffy et al., 1991; Rochefort, 1992) , we tried to establish the possible correlations between breast fluid and cytosol levels of this proteinase. Although the limited number of cases in which both values could be determined does not allow generalisation of results, it became apparent that there was no correlation between both parameters. According to this result, it can be argued that breast fluid composition does not reflect specifically the tumour metabolic activity within the mammary gland. However, it should be considered that tumour tissue homogenates used in the preparation of 'cytosol' fractions contain a wide variety of cellular components, including inflammatory cells with ability of producing large amounts of lysosomal enzymes as cathepsin D. Therefore, the specificity of biochemical assays based on tumour extracts will be subjected to the variable contribution of these non-tumour cathepsin D producing cells (Henry et al., 1990 ).
At present, and due to the short follow-up of patients whose breast fluid cathepsin D was measured, it is not possible to decide whether quantification of cathepsin D in breast secretions could be of importance as a complementary method to predict the clinical outcome of each particular patient. Similarly, it is not possible to define the clinical significance of the presence of high levels of cathepsin D in some nipple aspirates obtained from women with benign breast diseases or without breast pathologies. In relation to this, it should be mentioned that on the basis of cathepsin D measurements in breast cyst fluids, different laboratories , Scambia et al., 1991 S'anchez et al., 1992a) have proposed that this proteinase is a potential marker for distinguishing high-risk from low-risk benign breast diseases. Further studies and long-term clinical followup of the different subgroups of women, which are now in progress, could be useful to define the actual prognostic value of cathepsin D levels in breast secretions from women with breast cancer. These studies will be also useful to evaluate the possibility that accumulation of cathepsin D in these fluids could reflect the existence of lesions at increased risk of malignant transformation. 
